Where Pharma and Beauty Meet
The combined dermocosmetics and medical aesthetics markets have been growing double-digit over the past five years and will keep growing 2-3 points above the beauty market’s average rate*. Market indicators suggest that the growth of dermocosmetics will last. Sensitive skin problems are increasingly prevalent among the global population. Environmental and lifestyle conditions also impact skin health in the long term. Companies are increasingly investing in skin health domains like microbiome, exosome, longevity and digital health. The new generation of skincare treatments is rooted in science and dermatology. Either on their own or through partnerships with dermatologists, plastic surgeons and medical laboratories, dermocosmetics brands are launching premium formulations, which have their own specific requirements when it comes to packaging and dispensing.
Uncovering the Needs of the Derma Market
In response, Aptar Beauty’s Derma Series has been curated to address the needs, desires and pain points of this market. “We were early in detecting a need for dispensing solutions that went beyond the usual requirements for beauty products,” says Xavier Joseph, Vice President, Global Marketing & Innovation, at Aptar Beauty. “We went straight to the source and spoke to major customers and dermatologists, who revealed problems to be solved and opportunities to help them. Some are product-related, others revolve around capabilities.”
“We found we could provide a true value-added service, grounded in our deep understanding of this rapidly-growing market.”
“Our market analysis confirmed that we are able to offer not only the right dispensing technologies in key categories, but also inclusive design, material science know-how and digital health solutions. As part of AptarGroup, we are in the unique position to build on knowledge from Aptar Pharma and its vast experience in medical devices and pharmaceutical dispensing systems. This combination of cross-sector expertise, distinctive technology platforms and technical capabilities at scale means that Aptar Beauty has all it takes to be the one-stop partner on user experience in Derma.”
Aptar Beauty’s pro-active research showed that dermocosmetics formulations require precision dispensing and high-protection packaging that enhance both formula performance and the consumer experience. Packaging must also be capable of premiumization, while presenting a medical look and feel for differentiation. Brands themselves are faced with unique challenges on entering the market. They need to stimulate user-centric innovation and bridge regulatory fields, such as those between cosmetics and medical devices. They also need solutions that will support patient adherence to the treatment usage.
Xavier Joseph concludes: “Dermocosmetics products are fulfilling a real and growing need. These formulations with their potent actives, or low preservative protection systems, are continually evolving. As a leader in our field, we need to ensure they have the dispensing solutions to ensure optimal delivery.
“Our holistic “product & service” approach allows us to accompany these brands on their journey, as a single-source partner for dermocosmetics dispensing.”
*Sources: IQVIA CHC Global Insights, 2019-2023, with Dermocosmetics market extrapolation vs OTC Country Scope (incl. US, China…), IQVIA MIDAS (Rx Dermatology)
Derma Series features a curated selection of high-performance packaging and dispensing solutions perfectly adapted to the specifications of the dermocosmetics market. All technologies are compatible with skincare or personal care formulations: airless, cosmetic pumps, droppers, dispensing pumps, spray pumps and aerosols. Each packaging is capable of premiumization for shelf differentiation and offers sustainable features.
Want To Learn More About the Derma Series Products and Our Capabilities Beyond Dispensing?
